Q4 2025 · 13F-HR
DIADEMA PARTNERS LPholdings as filed
Filed 2026-02-17 · accession 0001892688-26-000036
$580.5M
Reported value
145
Positions
2025-12-31
Period end
The Brief · DIADEMA PARTNERS LP · Q4 2025
AI · grounded in 13F
DIADEMA PARTNERS LP initiated a new position in VRTX worth $44.6M. The fund also opened new stakes in XBI for $30.5M and JNJ for $24.1M. On the sell side, the fund closed its positions in BMY and SPY, reducing exposure by $14.0M and $13.3M respectively.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $40.0M | 6.90% | 88,300 | CALL | SOLE |
| 78464A870 | XBI | SPDR SERIES TRUST | $30.5M | 5.25% | 250,000 | PUT | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $29.7M | 5.11% | 100,600 | PUT | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $24.2M | 4.17% | 688,900 | CALL | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $23.7M | 4.08% | 328,000 | CALL | SOLE |
| 46090E103 | QQQ | INVESCO QQQ TR | $18.4M | 3.17% | 30,000 | PUT | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $17.9M | 3.08% | 105,300 | CALL | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $15.9M | 2.74% | 211,100 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $15.3M | 2.64% | 200,000 | PUT | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $14.0M | 2.41% | 345,880 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $13.8M | 2.37% | 66,444 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $13.3M | 2.30% | 191,700 | CALL | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $11.9M | 2.04% | 336,849 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $11.1M | 1.92% | 316,700 | PUT | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $10.7M | 1.84% | 139,600 | CALL | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $10.3M | 1.78% | 50,000 | CALL | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $10.2M | 1.76% | 75,644 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $9.9M | 1.70% | 100,000 | PUT | SOLE |
| 457669307 | INSM | INSMED INC | $9.2M | 1.58% | 52,800 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $9.0M | 1.55% | 312,300 | CALL | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.7M | 1.50% | 146,361 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.4M | 1.45% | 106,200 | CALL | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $8.0M | 1.37% | 10,300 | Common | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $7.9M | 1.36% | 220,300 | CALL | SOLE |
| N90064101 | QURE | UNIQURE NV | $7.2M | 1.24% | 301,800 | PUT | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $6.9M | 1.19% | 318,700 | PUT | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $6.6M | 1.14% | 545,200 | CALL | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $6.3M | 1.09% | 240,600 | CALL | SOLE |
| H17182108 | CRSP | CRISPR THERAPEUTICS AG | $5.9M | 1.02% | 112,700 | CALL | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $5.8M | 0.99% | 200,000 | PUT | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $5.4M | 0.92% | 70,000 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $4.9M | 0.84% | 10,000 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $4.7M | 0.81% | 134,800 | PUT | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $4.7M | 0.81% | 131,852 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $4.6M | 0.79% | 158,075 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $4.5M | 0.78% | 10,000 | Common | SOLE |
| 00182C103 | ANIP | ANI PHARMACEUTICALS INC | $4.2M | 0.73% | 53,354 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $3.9M | 0.66% | 5,000 | CALL | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.7M | 0.63% | 123,283 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $3.6M | 0.62% | 271,164 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $3.4M | 0.58% | 97,445 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $3.1M | 0.54% | 552,300 | CALL | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $3.0M | 0.52% | 741,900 | CALL | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $3.0M | 0.51% | 100,000 | PUT | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $3.0M | 0.51% | 243,170 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $2.9M | 0.51% | 37,020 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $2.8M | 0.49% | 316,900 | PUT | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $2.7M | 0.47% | 877,100 | CALL | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $2.7M | 0.47% | 53,100 | PUT | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $2.6M | 0.45% | 548,600 | CALL | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.6M | 0.45% | 64,700 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $2.5M | 0.42% | 53,100 | CALL | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $2.4M | 0.42% | 70,300 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $2.4M | 0.41% | 96,100 | CALL | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $2.3M | 0.40% | 683,611 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $2.3M | 0.40% | 100,000 | CALL | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $2.3M | 0.39% | 200,000 | CALL | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.3M | 0.39% | 90,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $2.2M | 0.39% | 230,997 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $2.2M | 0.38% | 337,700 | PUT | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $2.1M | 0.37% | 2,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $2.1M | 0.37% | 5,341 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $2.1M | 0.36% | 100,600 | CALL | SOLE |
| 53630X203 | LPCN | LIPOCINE INC NEW | $2.1M | 0.36% | 260,939 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $2.0M | 0.34% | 22,700 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $1.9M | 0.33% | 50,300 | PUT | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $1.9M | 0.33% | 212,400 | CALL | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $1.9M | 0.32% | 389,395 | Common | SOLE |
| 21900C308 | CRMD | CORMEDIX INC | $1.8M | 0.32% | 159,000 | PUT | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $1.8M | 0.31% | 200,000 | Common | SOLE |
| 02155H200 | ALT | ALTIMMUNE INC | $1.8M | 0.31% | 491,800 | CALL | SOLE |
| 921659108 | VNDA | VANDA PHARMACEUTICALS INC | $1.8M | 0.30% | 200,000 | CALL | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.8M | 0.30% | 350,000 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $1.7M | 0.29% | 302,000 | Common | SOLE |
| 81642T209 | SLS | SELLAS LIFE SCIENCES GROUP I | $1.6M | 0.28% | 424,900 | CALL | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $1.6M | 0.27% | 334,251 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.6M | 0.27% | 309,100 | CALL | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $1.5M | 0.26% | 69,000 | CALL | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $1.5M | 0.26% | 190,928 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $1.5M | 0.25% | 252,198 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $1.5M | 0.25% | 6,840 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $1.4M | 0.23% | 211,100 | CALL | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $1.3M | 0.23% | 170,568 | Common | SOLE |
| 766559702 | RIGL | RIGEL PHARMACEUTICALS INC | $1.3M | 0.22% | 30,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.2M | 0.21% | 26,892 | Common | SOLE |
| 695127100 | PCRX | PACIRA BIOSCIENCES INC | $1.2M | 0.21% | 48,025 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $1.2M | 0.21% | 97,184 | Common | SOLE |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $1.1M | 0.19% | 63,791 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.1M | 0.19% | 45,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.1M | 0.18% | 22,972 | Common | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $1.0M | 0.18% | 65,138 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $1.0M | 0.18% | 106,539 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $976,566 | 0.17% | 62,281 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $941,002 | 0.16% | 100,320 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $928,607 | 0.16% | 533,682 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $907,250 | 0.16% | 25,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $833,192 | 0.14% | 1,999,500 | CALL | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $827,616 | 0.14% | 29,600 | CALL | SOLE |
| 054754858 | AYTU | AYTU BIOPHARMA INC | $795,049 | 0.14% | 305,788 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $790,020 | 0.14% | 118,800 | CALL | SOLE |
| 171126204 | PTHS | PELTHOS THERAPEUTICS INC | $775,000 | 0.13% | 25,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $754,676 | 0.13% | 21,881 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $744,450 | 0.13% | 30,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $657,068 | 0.11% | 21,114 | Common | SOLE |
| 28106W103 | EDIT | EDITAS MEDICINE INC | $653,335 | 0.11% | 318,700 | CALL | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $622,096 | 0.11% | 47,200 | CALL | SOLE |
| G4766E116 | INDV | INDIVIOR PLC | $621,442 | 0.11% | 17,320 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $603,000 | 0.10% | 100,000 | Common | SOLE |
| 53220K504 | LGND | LIGAND PHARMACEUTICALS INC | $564,752 | 0.10% | 2,987 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $563,462 | 0.10% | 21,400 | PUT | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $556,575 | 0.10% | 20,500 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $545,325 | 0.09% | 17,181 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $538,459 | 0.09% | 347,393 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $537,876 | 0.09% | 89,200 | CALL | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $527,711 | 0.09% | 21,100 | CALL | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $510,790 | 0.09% | 21,810 | Common | SOLE |
| 032797300 | AVXL | ANAVEX LIFE SCIENCES CORP | $500,536 | 0.09% | 140,600 | CALL | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $483,300 | 0.08% | 22,500 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $462,672 | 0.08% | 190,400 | CALL | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $414,000 | 0.07% | 30,000 | CALL | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $408,870 | 0.07% | 53,100 | PUT | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $390,215 | 0.07% | 166,049 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $338,415 | 0.06% | 167,532 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $298,998 | 0.05% | 22,600 | CALL | SOLE |
| 413197104 | HRMY | HARMONY BIOSCIENCES HLDGS IN | $280,650 | 0.05% | 7,500 | Common | SOLE |
| 002942100 | AARD | AARDVARK THERAPEUTICS INC | $208,451 | 0.04% | 15,882 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $201,110 | 0.03% | 33,800 | CALL | SOLE |
| 64136E102 | NEUP | NEUPHORIA THERAPEUTICS INC | $194,000 | 0.03% | 50,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $176,795 | 0.03% | 144,914 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $174,000 | 0.03% | 100,000 | CALL | SOLE |
| 07725L102 | ONC | BEONE MEDICINES LTD | $172,784 | 0.03% | 7,500 | Common | SOLE |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $165,402 | 0.03% | 30,630 | Common | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $156,092 | 0.03% | 136,923 | Common | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $139,500 | 0.02% | 500,000 | CALL | SOLE |
| 746237106 | PRTCY | PURETECH HEALTH PLC | $123,835 | 0.02% | 7,442 | Common | SOLE |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $116,964 | 0.02% | 3,800 | PUT | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $102,621 | 0.02% | 1,299 | Common | SOLE |
| 27966L306 | EDSA | EDESA BIOTECH INC | $76,716 | 0.01% | 54,025 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $70,492 | 0.01% | 106,500 | CALL | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $66,190 | 0.01% | 100,000 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $20,988 | 0.00% | 10,600 | PUT | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $12,138 | 0.00% | 15,500 | CALL | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $9,241 | 0.00% | 11,800 | PUT | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $2,972 | 0.00% | 1,046 | PUT | SOLE |
| 03828A101 | APLT | APPLIED THERAPEUTICS INC | $2,020 | 0.00% | 20,200 | CALL | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.